IL-4 and IL-13 inhibit IL-1β and TNF-α induced kinin B 1 and B2 receptors through a STAT6-dependent mechanism
Nenhuma Miniatura disponível
Data
2013-05-06
Título da Revista
ISSN da Revista
Título de Volume
Editor
Resumo
Background and Purpose Bone resorption induced by interleukin-1β (IL-1β) and tumour necrosis factor (TNF-α) is synergistically potentiated by kinins, partially due to enhanced kinin receptor expression. Inflammation-induced bone resorption can be impaired by IL-4 and IL-13. The aim was to investigate if expression of B1 and B2 kinin receptors can be affected by IL-4 and IL-13. Experimental Approach We examined effects in a human osteoblastic cell line (MG-63), primary human gingival fibroblasts and mouse bones by IL-4 and IL-13 on mRNA and protein expression of the B1 and B2 kinin receptors. We also examined the role of STAT6 by RNA interference and using Stat6-/- mice. Key Results IL-4 and IL-13 decreased the mRNA expression of B1 and B2 kinin receptors induced by either IL-1β or TNF-α in MG-63 cells, intact mouse calvarial bones or primary human gingival fibroblasts. The burst of intracellular calcium induced by either bradykinin (B2 agonist) or des-Arg10-Lys-bradykinin (B1 agonist) in gingival fibroblasts pretreated with IL-1β was impaired by IL-4. Similarly, the increased binding of B1 and B2 ligands induced by IL-1β was decreased by IL-4. In calvarial bones from Stat6-deficient mice, and in fibroblasts in which STAT6 was knocked down by siRNA, the effect of IL-4 was decreased. Conclusions and Implications These data show, for the first time, that IL-4 and IL-13 decrease kinin receptors in a STAT6-dependent mechanism, which can be one important mechanism by which these cytokines exert their anti-inflammatory effects and impair bone resorption. © 2013 The Authors. British Journal of Pharmacology © 2013 The British Pharmacological Society.
Descrição
Palavras-chave
interleukin-1β, interleukin-13, interleukin-4, kinin receptors, STAT6, tumour necrosis factor-α, arginine, bradykinin B1 receptor, bradykinin B2 receptor, bradykinin B2 receptor agonist, bradykinin derivative, calcium, interleukin 13, interleukin 1beta, interleukin 4, lysine, messenger RNA, small interfering RNA, STAT6 protein, tumor necrosis factor alpha, animal cell, animal experiment, animal model, calcium cell level, calvaria, cell strain, cell strain mg 63, controlled study, fibroblast, gene expression, gingiva, human, human cell, ligand binding, mouse, nonhuman, osteoblast, priority journal, protein expression, protein function, protein protein interaction, receptor binding, RNA interference
Como citar
British Journal of Pharmacology, v. 169, n. 2, p. 400-412, 2013.